ATE248162T1 - Quinolincarbonsäure-derivate oder salze davon - Google Patents

Quinolincarbonsäure-derivate oder salze davon

Info

Publication number
ATE248162T1
ATE248162T1 AT00940804T AT00940804T ATE248162T1 AT E248162 T1 ATE248162 T1 AT E248162T1 AT 00940804 T AT00940804 T AT 00940804T AT 00940804 T AT00940804 T AT 00940804T AT E248162 T1 ATE248162 T1 AT E248162T1
Authority
AT
Austria
Prior art keywords
salts
acid derivatives
carbonic acid
extremely high
quinoline
Prior art date
Application number
AT00940804T
Other languages
English (en)
Inventor
Akira Yazaki
Yoshiko Niino
Yasuhiro Kuramoto
Yuzo Hirao
Yoshihiro Ohshita
Norihiro Hayashi
Hirotaka Amano
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Application granted granted Critical
Publication of ATE248162T1 publication Critical patent/ATE248162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00940804T 1999-07-01 2000-06-22 Quinolincarbonsäure-derivate oder salze davon ATE248162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (en) 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof

Publications (1)

Publication Number Publication Date
ATE248162T1 true ATE248162T1 (de) 2003-09-15

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940804T ATE248162T1 (de) 1999-07-01 2000-06-22 Quinolincarbonsäure-derivate oder salze davon

Country Status (25)

Country Link
US (1) US6858625B1 (de)
EP (1) EP1193266B1 (de)
JP (1) JP3477465B2 (de)
KR (1) KR100628414B1 (de)
CN (1) CN1157389C (de)
AT (1) ATE248162T1 (de)
AU (1) AU766014B2 (de)
BR (1) BR0012192A (de)
CA (1) CA2376760C (de)
CZ (1) CZ302033B6 (de)
DE (1) DE60004846T2 (de)
DK (1) DK1193266T3 (de)
ES (1) ES2206257T3 (de)
HK (1) HK1047103B (de)
HU (1) HUP0201549A3 (de)
IL (2) IL147043A0 (de)
MX (1) MXPA02000103A (de)
NO (1) NO321803B1 (de)
NZ (1) NZ516201A (de)
PT (1) PT1193266E (de)
RU (1) RU2236408C2 (de)
SK (1) SK285814B6 (de)
TW (1) TW576832B (de)
WO (1) WO2001002390A1 (de)
ZA (1) ZA200110357B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017991A1 (en) * 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or its salt
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
JP3995705B2 (ja) * 2004-11-17 2007-10-24 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩
PL3766876T3 (pl) * 2008-09-24 2024-04-02 Melinta Subsidiary Corp. Preparat farmaceutyczny zawierający pochodną chinolonu

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548664B1 (fr) * 1983-07-06 1986-03-21 Provesan Sa Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
NO177302C (no) 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
EP0713487B1 (de) * 1993-08-13 2000-04-19 Dong Wha Pharmaceutical Industrial Co. Ltd. Neue chinoloncarbonsäurederivate
EP0787720B1 (de) * 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
DK0992501T3 (da) * 1995-09-22 2002-10-28 Wakunaga Pharma Co Ltd Pyridoncarboxylsyre derivater som antibakterielle midler
PT897919E (pt) * 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
US6136823A (en) * 1996-11-28 2000-10-24 Wakunaga Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
CA2376760A1 (en) 2001-01-11
RU2236408C2 (ru) 2004-09-20
AU5567900A (en) 2001-01-22
KR100628414B1 (ko) 2006-09-26
US6858625B1 (en) 2005-02-22
CN1358183A (zh) 2002-07-10
AU766014B2 (en) 2003-10-09
HUP0201549A3 (en) 2003-11-28
ZA200110357B (en) 2002-12-18
ES2206257T3 (es) 2004-05-16
EP1193266A4 (de) 2002-08-14
EP1193266A1 (de) 2002-04-03
HK1047103B (zh) 2005-04-08
NO321803B1 (no) 2006-07-03
HUP0201549A2 (en) 2002-08-28
JP3477465B2 (ja) 2003-12-10
CZ20014598A3 (cs) 2002-05-15
DE60004846T2 (de) 2004-06-03
IL147043A0 (en) 2002-08-14
TW576832B (en) 2004-02-21
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (en) 2001-01-11
BR0012192A (pt) 2002-06-18
CZ302033B6 (cs) 2010-09-08
NZ516201A (en) 2003-06-30
MXPA02000103A (es) 2003-07-21
EP1193266B1 (de) 2003-08-27
DK1193266T3 (da) 2003-11-24
SK285814B6 (sk) 2007-08-02
CA2376760C (en) 2008-11-25
HK1047103A1 (en) 2003-02-07
DE60004846D1 (de) 2003-10-02
PT1193266E (pt) 2003-12-31
CN1157389C (zh) 2004-07-14
SK19162001A3 (sk) 2002-06-04
IL147043A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
DK0609606T3 (de)
CY1120169T1 (el) Παραγωγο αμιδιου και φαρμακο
MXPA05013712A (es) Derivados de acido propionico, utiles en el tratamiento de trastornos de lipidos.
ATE128707T1 (de) Quinoloncarbonsäurederivat.
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
KR870006034A (ko) 항균제로서의 5-아미노 및 5-하이드록시- 6,8-디플루오로퀴놀론
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE248162T1 (de) Quinolincarbonsäure-derivate oder salze davon
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
DE602004009079D1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
JP3424038B2 (ja) 合成抗菌剤水性組成物
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
ES8506009A1 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
EP1219618A4 (de) Qunolin-carbonsäure-derivate oder ihre salze
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
WO2003013530A3 (de) Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
EP1295881A4 (de) Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria
WO2003035058A3 (en) Polymaleide compounds and their medical use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1193266

Country of ref document: EP

REN Ceased due to non-payment of the annual fee